Lv4
518 积分 2024-11-04 加入
Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase‐1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose study
17天前
已关闭
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
29天前
已完结
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
29天前
已完结
Safety, tolerability, pharmacokinetics(PK) and pharmacodynamics(PD) of HSK31858，a novel DPP-1 inhibitor in healthy volunteers：a phase I clinical trial
1个月前
已关闭
Index of Psychological Well-Being at Work
1个月前
已关闭
Phase I clinical trial of YM617, a new α_1-adrenoceptor antagonist. Second report: A single oral dose of controlled release formulation in healthy male subjects
2个月前
已关闭
Tamsulosin (Harnal, Flomax, OMNIC)
2个月前
已完结
Individual Work Performance Questionnaire--American-English Version
2个月前
已关闭
Psychological Well-Being at Work Measures
2个月前
已完结
Rapid Efficacy of the Highly Selective α 1A -Adrenoceptor Antagonist Silodosin in Men With Signs and Symptoms of Benign Prostatic Hyperplasia: Pooled Results of 2 Phase 3 Studies
4个月前
已关闭
FUBP3 mediates the amyloid-β-induced neuronal NLRP3 expression
皖公网安备34019202002308
